CN114028517A - 妇康通宝丸 - Google Patents
妇康通宝丸 Download PDFInfo
- Publication number
- CN114028517A CN114028517A CN202110617724.0A CN202110617724A CN114028517A CN 114028517 A CN114028517 A CN 114028517A CN 202110617724 A CN202110617724 A CN 202110617724A CN 114028517 A CN114028517 A CN 114028517A
- Authority
- CN
- China
- Prior art keywords
- blood
- pill
- fukangtong
- basis
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006187 pill Substances 0.000 title claims abstract description 21
- 206010061218 Inflammation Diseases 0.000 claims abstract description 23
- 230000004054 inflammatory process Effects 0.000 claims abstract description 23
- 206010046798 Uterine leiomyoma Diseases 0.000 claims abstract description 14
- 208000002495 Uterine Neoplasms Diseases 0.000 claims abstract description 7
- 206010046766 uterine cancer Diseases 0.000 claims abstract description 7
- 208000000509 infertility Diseases 0.000 claims abstract description 4
- 230000036512 infertility Effects 0.000 claims abstract description 4
- 231100000535 infertility Toxicity 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 27
- 229940079593 drug Drugs 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000237502 Ostreidae Species 0.000 claims description 7
- 208000031513 cyst Diseases 0.000 claims description 7
- 235000020636 oyster Nutrition 0.000 claims description 7
- 241000131329 Carabidae Species 0.000 claims description 6
- 206010011732 Cyst Diseases 0.000 claims description 6
- 239000004863 Frankincense Substances 0.000 claims description 6
- 241000270666 Testudines Species 0.000 claims description 6
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 5
- 240000007551 Boswellia serrata Species 0.000 claims description 5
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 5
- 240000009138 Curcuma zedoaria Species 0.000 claims description 5
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 240000009022 Smilax rotundifolia Species 0.000 claims description 5
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 5
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims description 5
- 235000019509 white turmeric Nutrition 0.000 claims description 5
- 240000001659 Oldenlandia diffusa Species 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000009910 sargent gloryvine Substances 0.000 claims description 4
- 241000288784 Barleria cristata Species 0.000 claims description 3
- 240000007311 Commiphora myrrha Species 0.000 claims description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 3
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 244000164480 Curcuma aromatica Species 0.000 claims description 3
- 241000241550 Cyathula Species 0.000 claims description 3
- 241000096284 Gynochthodes officinalis Species 0.000 claims description 3
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 3
- 241000972673 Phellodendron amurense Species 0.000 claims description 3
- 240000003152 Rhus chinensis Species 0.000 claims description 3
- 235000014220 Rhus chinensis Nutrition 0.000 claims description 3
- 241000915604 Scutellaria barbata Species 0.000 claims description 3
- 241000246044 Sophora flavescens Species 0.000 claims description 3
- 241000205578 Thalictrum Species 0.000 claims description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 3
- 244000116484 Inula helenium Species 0.000 claims description 2
- 235000002598 Inula helenium Nutrition 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 229940107666 astragalus root Drugs 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 229920002261 Corn starch Polymers 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 229940126680 traditional chinese medicines Drugs 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 63
- 239000008280 blood Substances 0.000 abstract description 63
- 230000000694 effects Effects 0.000 abstract description 41
- 201000010099 disease Diseases 0.000 abstract description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 31
- 206010028980 Neoplasm Diseases 0.000 abstract description 23
- 208000002193 Pain Diseases 0.000 abstract description 22
- 230000036407 pain Effects 0.000 abstract description 22
- 201000011510 cancer Diseases 0.000 abstract description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 13
- 208000026435 phlegm Diseases 0.000 abstract description 13
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 230000004087 circulation Effects 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 8
- 230000001717 pathogenic effect Effects 0.000 abstract description 8
- 230000007812 deficiency Effects 0.000 abstract description 5
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 238000009499 grossing Methods 0.000 abstract description 3
- 206010061692 Benign muscle neoplasm Diseases 0.000 abstract description 2
- 201000004458 Myoma Diseases 0.000 abstract description 2
- 210000003754 fetus Anatomy 0.000 abstract description 2
- 208000025661 ovarian cyst Diseases 0.000 abstract description 2
- 230000014509 gene expression Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 27
- 210000004291 uterus Anatomy 0.000 description 12
- 206010042674 Swelling Diseases 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000003213 activating effect Effects 0.000 description 8
- 231100000331 toxic Toxicity 0.000 description 8
- 230000002588 toxic effect Effects 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 235000006533 astragalus Nutrition 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004233 talus Anatomy 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 201000010260 leiomyoma Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 208000010579 uterine corpus leiomyoma Diseases 0.000 description 4
- 201000007954 uterine fibroid Diseases 0.000 description 4
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 3
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 3
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 3
- 229910001369 Brass Inorganic materials 0.000 description 3
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 3
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 3
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 3
- 239000010951 brass Chemical class 0.000 description 3
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 3
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- -1 glutamic acid Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000015500 sitosterol Nutrition 0.000 description 3
- 229950005143 sitosterol Drugs 0.000 description 3
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 244000272264 Saussurea lappa Species 0.000 description 2
- 235000006784 Saussurea lappa Nutrition 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 210000004246 corpus luteum Anatomy 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- LQERIDTXQFOHKA-UHFFFAOYSA-N nonadecane Chemical compound CCCCCCCCCCCCCCCCCCC LQERIDTXQFOHKA-UHFFFAOYSA-N 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- KDPFMRXIVDLQKX-ISGXEFFDSA-N (+)-Curdione Natural products CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)/CC1=O KDPFMRXIVDLQKX-ISGXEFFDSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- HRYLQFBHBWLLLL-UHFFFAOYSA-N (+)-costunolide Natural products C1CC(C)=CCCC(C)=CC2OC(=O)C(=C)C21 HRYLQFBHBWLLLL-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- XZRVRYFILCSYSP-OAHLLOKOSA-N (-)-beta-bisabolene Chemical compound CC(C)=CCCC(=C)[C@H]1CCC(C)=CC1 XZRVRYFILCSYSP-OAHLLOKOSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- KNOUERLLBMJGLF-UHFFFAOYSA-N 1-bisabolone Natural products CC(C)=CCCC(C)C1CCC(C)=CC1=O KNOUERLLBMJGLF-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008671 Calycanthus floridus Nutrition 0.000 description 1
- 244000025311 Calycanthus occidentalis Species 0.000 description 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000004310 Cinnamomum zeylanicum Nutrition 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- CUGKULNFZMNVQI-UHFFFAOYSA-N Costunolid I Natural products CC1=CCC=C(/C)CCC2C(C1)OC(=O)C2=C CUGKULNFZMNVQI-UHFFFAOYSA-N 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WKSUCCVMYJRMFR-UHFFFAOYSA-N Dehydrocostus lactone Natural products C12OC(=O)C(=C)C2CCC(=C)C2(C)C1(C)C(=C)CC2 WKSUCCVMYJRMFR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 206010061977 Genital infection female Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- KDPFMRXIVDLQKX-NHFJXKHHSA-N Germacr-1(10)-ene-5,8-dione Chemical compound CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)\CC1=O KDPFMRXIVDLQKX-NHFJXKHHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010018762 Grunting Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 235000004520 Lindera benzoin Nutrition 0.000 description 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000157511 Oldenlandia Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229940123237 Taxane Drugs 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000007824 aliphatic compounds Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- HRYLQFBHBWLLLL-AHNJNIBGSA-N costunolide Chemical compound C1CC(/C)=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]21 HRYLQFBHBWLLLL-AHNJNIBGSA-N 0.000 description 1
- MMTZAJNKISZWFG-UHFFFAOYSA-N costunolide Natural products CC1CCC2C(CC(=C/C=C1)C)OC(=O)C2=C MMTZAJNKISZWFG-UHFFFAOYSA-N 0.000 description 1
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 1
- KDPFMRXIVDLQKX-UHFFFAOYSA-N curdione Natural products CC(C)C1CC(=O)C(C)CCC=C(C)CC1=O KDPFMRXIVDLQKX-UHFFFAOYSA-N 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- NETSQGRTUNRXEO-XUXIUFHCSA-N dehydrocostus lactone Chemical compound C([C@H]1C(=C)C(=O)O[C@@H]11)CC(=C)[C@H]2[C@@H]1C(=C)CC2 NETSQGRTUNRXEO-XUXIUFHCSA-N 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 208000037922 refractory disease Diseases 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Animal Husbandry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
妇科炎症、***、子宫肌瘤、或子宫癌,还有中医常说的宫寒***症,这些疾病为妇科常见病。我研发妇康通宝丸治疗效果很好,顾明议“通”是治疗本病的关键,炎症消了,肌瘤小了,癌症减轻了,则寒散气血调和,自然就能怀孕生子,所以取名为妇康通宝丸。痛则不通,有人认为寒凝,有人认为瘀血,还有人认为肾虚,其实每一种说法都有些片面性,只有抓住疾病的本质,疗效自然会显著。我认为阴和血在人体内的运行,是人体最重要的物质基础,应称之为本,瘀血、痰湿、邪毒为标,标和本往往相互影响,使气血运行阻滞,病邪积聚日久而发为本病,因此以驱邪、通畅、解毒为主,兼以扶正固本则是治疗本病的关键。
Description
妇康通宝丸是我经过多年的临床实验,并不断摸索、研究、完善而成,此配方组成如下:炙鳖甲7一 0克、牡蛎60克、瓦楞子50克、黄芪50克、当归60克、巴戟天60克、乳香50克、没药40克、三棱 40克、莪术40克、乌药50、木香60、川牛膝30克、土鳖虫20克、五倍子40克、红藤30克、土茯苓 30克、紫花地丁30克、穿心连30克、半枝莲20克、白花蛇舌草30克、苦参50克、黄柏50克等。配方的功能具有滋阴补阳、益气养血、软坚散结、行气活血、利湿化痰、祛浊解毒等。根据这些功效,能够有效的治疗妇科炎症、宫寒***、***、子宫肌瘤、子宫癌等顽疾。这些疾病最常见的都有哪些主要症状呢?主要有***或经期延长、闭经、痛经、或下腹部胀痛、按之有包块、白带或黄带多而有异味、小腹经常感觉凉、以及手脚不温,腰痛、或腿部感觉凉而怕风或麻木,走路腿沉重而无力、气血不足、睡眠不好等。
这些疾病的病理机制,中医认为人体阴阳平衡,气血调和,循环周流、旺盛是维持身体健康的关键。当人体因各种原因一旦阴阳失去平衡,气血不足,血液运行则缓慢、阻滞,从而产生痰湿、瘀血块、病原微生物细菌或各种病毒乘虚而入,这种瘀血块、痰湿、浊阴之毒积聚在子宫内部,从而引起上述这些疾病的发生、发展。这种痰湿、浊阴之毒反过来还会阻遏阳气,或病灶压迫血管或影响到神经,而使人体的元阳受损,甚至更加气血不足,从而导致人体免疫力下降,疾病加重,病灶毒性若较大且日久不愈,局部细胞基因变性而变成癌细胞,最终转化为癌症。
妇康通宝丸制作方法并不复杂,首先按照配方的比例把药配好,然后应用打粉机将药打成200目的细药粉,然后加入适量的淀粉粘合剂充分搅拌均匀,将搅拌均匀的细药粉,应用全自动制丸机制成水丸,然后在把制成的水丸用烘干机烘干即可。在给患者进行治疗时,应根据患者的病情轻重,每日服用二至三次,每次8克连服2到3个月。根据患者疾病的好转情况,可以在延长几个月,以至充分让疾病得到控制并逐渐恢复健康。
那么妇康通宝丸的治疗效果怎样呢?根据众多患者服药情况的亲身体会,以及患者服药后的反馈和总结来看,此配方疗效甚是显著,总有效率达百分之百。能够迅速减轻或缓解疾病的症状,患者服用后感觉腹内及小腹部,会有一种行气的感觉,时而发出咕噜咕噜的响声,而且排大小便也很畅通。连续几个月或半年不来月经的患者,在服用后一般在十天左右月经就会来,腹部感觉凉或腿部怕风、怕凉、无力、麻木的症状很快就会好转,而感觉两腿走路有力、身体轻松。还有的患者在服用妇康通宝丸后而逐渐的把子宫内的瘀血块排除干净,之后月经淋漓不断,经期延长的症状也会逐渐的恢复正常。有很多患有子宫肌瘤的患者,在服用1到2个月后,去医院做仪器检测,通过检测报告,在服用前和服用后进行对比,发现子宫肌瘤却有明显的萎缩变小。有部分子宫癌的患者在服用后,也会感觉到病情有明显的减轻并好转。
那么什么样的人不应服用妇康通宝丸呢?虽然妇康通宝丸以攻邪通畅为主兼以扶正,治疗妇科疾病范围较广,但也有它应当禁忌的病症。假如患者有子宫严重出血的症状,一定要禁服此药,这样的患者,可能是因为子宫内的肌瘤较大,压迫或影响到血管所至,应当尽快采取手术切除治疗,出血才会好转,好转以后服用妇康通宝丸比较适合,以彻底巩固恢复并根除手术残留下来的不足。另一种情况就是,妇女当发现自己怀孕以后,就应当禁服此药,因为孕妇以后应当以养血、补肾、安胎为主,而此药是以行气活血攻邪杀毒通畅为主,而兼以扶正,毕竟养血安胎的药物少,在妇女怀孕以后就不适合服用此药的。若是在产后有瘀血阻滞,恶露不下最为得当。
那么配方的组成原理是什么呢?人体好比是一条清水河,只要水来有源,河水就不会干枯就会流动。古人也曾经说过:流水不腐,户枢不蠹。那么拿我们人体来说,清水又比喻什么呢?清水就好比是人体的阴和血,阴不虚则生血有源,则血就不会干枯、亏少、粘稠,阴阳平衡、气血调和、运行没有阻滞,就不会出现气滞血瘀,而有瘀血块、痛经的症状、痰浊、湿毒也不容易侵入、滞留、积聚而形成疾病。因此配方中滋阴、补阳、益气、养血、有利于提高人体免疫***的功能,在此基础上清除子宫内的垃圾物质,包括痰浊、瘀血块,并杀灭病原微生物细菌、病毒,抑制癌细胞生长,祛瘀生新,降浊升阳而净化子宫内部的环境,这样才有利于恢复并保持子宫内的气血循环通畅,而达到祛病治癌的效果。
炙鳖甲性凉具有,滋阴养血、软坚散结,解毒抗癌等功效。具现代药理研究,由于炙鳖甲含有丰富的角蛋白、骨胶原蛋白、钙和铁的含量也很丰富,能提高血红蛋白的含量,有补血的作用,既能软坚散结,又能滋阴补肾,能养血,所以用量要大,有利于妇科疾病的恢复。牡蛎具有,滋阴养血、软坚散结、收敛固涩、清浊化痰等功效。它主要含有牛黄酸等物质,可以促进胆汁的分泌,排出堆积在肝脏中的中性脂肪,而提高肝脏的解毒作用。由于牡蛎有软坚、散结、滋阴、补肾、养血、化痰浊的功效,所以非常适用于治疗子宫肌瘤等妇科疾病。炙鳖甲和牡蛎皆能滋阴补肾养血,所以用量要重些。瓦楞子具有,软坚散结、活血化瘀、化痰祛浊、治酸止痛、抗溃疡等的作用。它含有大量的碳酸钙、少量的磷酸钙、尚含少量的镁和铁柜、硅酸盐、硫酸盐、氯化物及有机质。它对人体的瘀血不通以及女性的闭经和***等症,都有明显的治疗作用。牡蛎和瓦楞子两味药,均有化痰浊的功效,对治疗囊肿、子宫肌瘤有效果。生黄芪具有补气升阳、益卫固表、利水消肿、托疮生肌的功效。它主要含有黄芪皂苷、黄芪多糖、黄铜类化合物、还有氨基酸、蛋白质、核黄酸、叶酸、微生素D、谷甾醇、胡萝卜苷、咖啡酸、绿原酸及微量元素等多种成分。黄芪多糖能促进RNA和蛋白合成,使细胞生长旺盛,寿命延长,并能抗疲劳,抗流感病毒。黄芪多糖、皂苷对造血功能有促进作用。应用黄芪能补气生血,用于防治妇女因妇科疾病而导致的月经量枯少等症状。当归具有,活血通络、补血养血、润肠通便的作用。它含有丰富的氨基酸、和铁、钙、铜、锌、钾等微量元素,有利于促进机体造血功能,从而达到补血的作用,并有利于提高人体的免疫力。女性服用当归可以补血调经,活血止痛,减轻痛经的症状,调理月经,并防止因妇科疾病而出现月经量不足的情况。巴戟天具有补肾壮阳、强筋骨、祛风湿的作用。它含有维生素C大黄素甲醚、棕榈酸、十九烷、谷甾醇、甲基异茜素、糖类及蒽醌类等。主治肾阳不足、肢体不温、小腹冷痛、子宫虚寒、风寒湿瘅、妇科炎症、并有有抗炎利尿的作用,能促进卵巢***,和黄体生成,并维持黄体等功能。炙鳖甲、牡蛎、瓦楞子这三味药同时应用,能起到软坚、散结、化瘀、消痰、化瘤、抗癌的作用。炙鳖甲、牡蛎、黄芪、当归、巴戟天这五味药同时应用,起到滋阴补肾、益气养血、升阳祛寒的作用,有利于在治疗妇科疾病中,能维持正常的月经量,而有利于妇女能怀孕生子。
乳香具有,活血、行气、化瘀、抗炎、消肿、生肌、止痛等功效。它含有香脂酸、乳香脂烃、乳香次酸、乳香酸等。另含挥发油主要为蒎烯。有镇痛、消炎、升高白细胞的作用,并能加速炎症渗出、***,促进伤口愈合,所含蒎烯有祛痰的作用。没药具有,活血行气、消肿止痛、抗炎生肌的作用。它含有a罕没药酸、B罕没药酸、没药尼酸、没药贴春、丁香油酚、柠檬烯、没药烯等成分。它具有很好的抗炎作用,水浸剂在试管内对董色毛癣菌、同心性毛癣菌、许兰黄癣菌等多种致病性皮肤真菌有不同程度的抑制作用,其抗菌作用可能与所含丁香酚有关。三棱具有,破血行气、消炎止痛的作用。它含有挥发油,主要成分为笨乙醇、对笨二酚、十六酸、去氢木香内脂、琥珀酸、三棱酸等。具有镇痛和升高白细胞的作用,能促进单核细胞的吞噬功能,促进巨噬细胞向血块周围聚集吞噬的作用,对肿胀性炎症有抗炎及镇痛的作用。常用于治疗各种囊肿、肌瘤、肿瘤、瘀血经闭、痛经、胸痹心痛、食积气滞、导致的脘腹胀满,胀痛的症状。莪术性温,具有破血行气、消积止痛的作用。它含有挥发油、黄铜类、萜类等化学成分。主要有莪术呋喃唑酮、莪术醇、龙脑、大栊牛儿酮、樟脑、姜黄烯、莪术二酮、桂莪术内脂,胡萝卜苷,B谷团醇,棕相酸等成分。具现代药理研究莪术具有抗癌、抗菌、及升高白细胞的作用。莪术挥发油试管内能抑制金黄色葡萄球菌、溶血性链球菌、大肠挨希菌、伤寒杆菌、霍乱弧菌等的生长。乌药具有,行气止痛、温肾散寒的功效。乌药善于疏通气机,温散寒邪,因此可以有较好的行气、散寒、止痛等功效。也可用于寒凝气滞所引起的胸腹胀痛,寒凝肝脉所出现的疝气腹痛,经寒腹痛可以用乌药来治疗。木香性温,具有理气的重要作用,能疏肝理气,能通理上下诸气。木香含有大量的挥发油成分,其中包括紫衫烯、木香烯内酯、这类物质具有很好的抗菌作用,能够抑制链球菌,金黄色与白色葡萄球菌的生长,因为木香本身具有抗菌消炎的作用,而且理气的作用很强,所以非常适用于治疗妇科疾病。川牛膝性平,具有滋补肝肾、逐瘀通经、利尿通淋、通利关节等功效。由于川牛膝性善下行,常用于活血通经,又能逐瘀止痛,所以对妇科、伤科、各种瘀血凝滞的病症应用较多。临床常用于血滞经闭、痛经、月经不畅、产后淤滞腹痛、妇科肿瘤及包块、跌打损伤的血肿疼痛等。土鳖虫具有,逐瘀、破积、活血、通络、理伤等功效。具现代药理研究发现土鳖虫含有的主要成分为谷氨酸等17种氨基酸,和砷等28种微量原素,及甾醇和直链脂肪族化合物等。由于土鳖虫含有的氨基酸和矿物质非常丰富以及很强的活血化瘀、祛瘀生新以及抗癌的作用,所以非常适用于妇科疾病的治疗。乳香、没药、三棱、莪术、乌药、木香、川牛膝、土鳖虫这八味药同时应用,能增强活血化瘀、行气止痛、祛瘀生新的作用力,对排除子宫内的瘀血块,净化子宫内的环境,以及抗囊肿、子宫肌瘤、癌症等起到很重要的作用。同时对治疗卵巢,输卵管堵塞,能起到很好的治疗通畅的作用,这对于妇女能够怀孕,起到很重要的作用。
五倍子具有,败毒抗癌、收敛止血、医疮消肿的功效。具现代药理研究发现,它含有五倍子鞣质、没食子酸、酸树脂等。五倍子鞣质能破坏癌细胞原鞣质具有抗肿瘤作用,对小鼠肉瘤S-180,人体***细胞JTC-26的抑制率均达90%以上。酸树脂对黏膜、皮肤组织溃疡有显著的收敛作用,煎剂对金黄色葡萄球菌、肺炎球菌、链球菌、伤寒杆菌、痢疾杆菌、白喉杆菌、炭疽杆菌、绿脓杆菌等均有一定的抑制或杀灭作用。红藤具有,活血通络、败毒散瘀、祛风杀虫、理气生血等功效。它含有大黄素、大黄素甲醚、B-甙谷甾醇,胡萝卜甙、硬脂酸、毛柳甙等。临床主要用于治疗肠痈腹痛,热毒疮疡、泌尿***感染、以及痛经、闭经、囊肿、子宫肌瘤、肿瘤均有较好的治疗作用。土茯苓具有,通淋、祛湿、解毒、通利关节的作用。事实上土茯苓是用来治疗比较严重的疮毒,据说土茯苓是治疗梅毒的要药,所以它对妇女的梅毒、***炎、妇科炎症、黄带多而有异味,有非常好的治疗效果。紫花地丁具有,清热解毒、凉血消肿的功效。它富含黄铜类成分,属于多酚化合物,这类化合物具有抗癌、抗氧化等多方面的药理作用。其中还含有多种微量元素,具有清热解毒和抗菌消炎的作用,对子宫癌和妇科炎症有很好的治疗效果。穿心连具有,清热解毒、凉血消肿、止痛、抗癌、抗炎、抗感染的效果非常好。常用于泄泻痢疾、热淋涩痛、痈肿疮疡、痢疾、***、呼吸***的感染及外伤感染的消炎、消肿、止痛、妇科炎症、子宫肌瘤、癌症均有很好的效果。半枝莲具有,清热解毒、抗菌消炎、活血化瘀、抗癌止痛、利水消肿等功效。常用于治疗水肿、恶疮肿毒、肝炎、妇科炎症、子宫肌瘤、子宫癌等都有很好的治疗效果。白花蛇舌草具有,清热解毒、消肿止痛、活血利尿、收敛利湿、抗炎抗癌等功效。临床常用于治疗扁导体炎、***、阑尾炎、肝炎、肿瘤、肺痈、肠痈消化道及淋巴肿瘤以及妇科炎症、子宫肌瘤、囊肿、癌症均有很好的治疗作用。现代药理研究证明,白花蛇舌草能够增强机体的免疫力,抑制肿瘤细胞的增长,对绿脓杆菌、金黄色葡萄球菌、肺炎球菌、痢疾杆菌均有明显的抑制作用。苦参具有,祛湿、解毒、杀虫、抗肿瘤、抗过敏、抗菌等功效。具现代药理研究,苦参所含有的苦参碱具有抗癌活性,对癌细胞具有不同程度的抑制作用。药理研究显示,苦参中的其它生物碱对细菌的呼吸和核酸代谢有抑制作用,对痢疾杆菌、变形杆菌、金黄色葡萄球菌、均有一定的抑制作用。黄柏具有滋补肾阴、祛虚热、清热解毒、燥湿疗疮、抗溃疡、抗癌等功效。它含有小孽碱、木兰碱、挥发油、豆固醇、黄柏铜等成分。具有抗病原微生物及原虫的作用。具有一定的解热、抗炎、化痰和抗溃疡的作用,对幽门螺杆菌及人型结核杆菌均匀有明显的抑制作用。五倍子、红藤、土茯苓、紫花地丁、穿心连、半枝莲、白花蛇舌草、苦参、黄柏这九味药联合应用,能够增强其解毒、祛湿、化浊、抗炎、抗癌的作用力,只有能够把引起妇科疾病的病邪给予消除,那么妇科炎症、囊肿、子宫肌瘤、子宫癌这些顽疾,才能逐渐的好转,肾的元阳之气才能慢慢的转阳回来,机体阴阳才能平衡,体质才能逐渐的恢复健康。
综上所述,妇康通宝丸所有的药物组成,都是根据妇科疾病的病因、病理特点,合理搭配而成的,药物之间不会发生冲突以及有不良反应。妇康通宝丸以治疗妇科顽固性疾病为主,对妇科炎症,宫寒***,囊肿、子宫肌瘤,子宫癌症等,药物以联合攻邪,祛瘀、祛浊、利湿、杀菌、解毒、以气机通畅为主,兼以滋阴、养血、扶阳以扶正,药物间相辅相成,协同发挥作用,形成一种攻坚必溃的作用力。对于治疗子宫,净化子宫,恢复子宫内的健康,使妇女逐渐的阴阳恢复平衡,气机通畅,气血调和,月经恢复正常而有利于妇女怀孕生子,其治疗功效上的显著,而令人满意,实乃难得的好配方。
Claims (2)
1.中药配方发明“妇康通宝丸”是一款以治疗:妇科炎症、宫寒***、囊肿、子宫肌瘤、子宫癌的配方组合物,组成如下:炙鳖甲70克、牡蛎60克、黄芪50克、当归60、巴戟天60克、瓦楞子60克、乳香50克、没药40克、三棱40克、莪术40克、乌药50克、木香60克、川牛膝30克、土鳖虫20克、五倍子40克、红藤30克、土茯苓30克、紫花地丁30克、穿心连30克、半枝莲20克、白花蛇舌草30克、苦参50克、黄柏50克等。
2.制作方法分为五步
第一步、按配方将此药混合在一起
第二步、用打粉机将混合在一起的中药打成200目的细药粉
第三步、加入适量的玉米淀粉调成的浆糊作为粘合剂,并充分搅拌均匀
第四步、将搅拌均匀的细药粉,放入全自动制丸机制成水丸
第五步、将制成的水丸装入烘干机内,烘干即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110617724.0A CN114028517A (zh) | 2021-06-02 | 2021-06-02 | 妇康通宝丸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110617724.0A CN114028517A (zh) | 2021-06-02 | 2021-06-02 | 妇康通宝丸 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114028517A true CN114028517A (zh) | 2022-02-11 |
Family
ID=80134214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110617724.0A Pending CN114028517A (zh) | 2021-06-02 | 2021-06-02 | 妇康通宝丸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114028517A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1500501A (zh) * | 2002-11-12 | 2004-06-02 | 王红波 | 治疗子宫肌瘤的中药复方制剂 |
CN104887983A (zh) * | 2015-05-13 | 2015-09-09 | 於朝琴 | 一种治疗妇科疾病的中药配方及其制备方法 |
CN105012894A (zh) * | 2015-08-21 | 2015-11-04 | 熊玉雪 | 一种治疗妇科疾病中药 |
-
2021
- 2021-06-02 CN CN202110617724.0A patent/CN114028517A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1500501A (zh) * | 2002-11-12 | 2004-06-02 | 王红波 | 治疗子宫肌瘤的中药复方制剂 |
CN104887983A (zh) * | 2015-05-13 | 2015-09-09 | 於朝琴 | 一种治疗妇科疾病的中药配方及其制备方法 |
CN105012894A (zh) * | 2015-08-21 | 2015-11-04 | 熊玉雪 | 一种治疗妇科疾病中药 |
Non-Patent Citations (4)
Title |
---|
叶玉妹: "消症合剂治疗子宫内膜异位症43例", 实用中医药杂志, vol. 17, no. 05, pages 1 * |
张小华;等: "丹黄祛瘀胶囊配合超短波治疗***100例", 陕西中医学院学报, vol. 31, no. 04, pages 47 - 48 * |
蒋继芳: "莪棱消瘤汤治疗子宫肌瘤60例疗效观察", 山东中医杂志, vol. 21, no. 04, pages 215 * |
赵英: "桂枝茯苓丸治疗妇科病临床研究", 河北中医药学报, vol. 31, no. 01, pages 30 - 31 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105560662A (zh) | 一种治疗膝关节骨性关节炎的外用中药组合物 | |
CN102488814B (zh) | 治疗奶牛***炎的中药组合物 | |
CN106138733A (zh) | 一种治疗皮肤病的中药膏制剂及其制备方法 | |
CN101658657B (zh) | 一种用于治疗慢性胆囊炎的药物 | |
CN103520439A (zh) | 一种治疗热毒蕴结型慢性骨髓炎的中药及其制备方法 | |
CN105412867A (zh) | 一种用于妇产科术后的中西药物及其制备方法 | |
CN114028517A (zh) | 妇康通宝丸 | |
CN113181318A (zh) | 一种治疗痔疮的中药药膏及其制备方法 | |
CN105582475A (zh) | 一种妇产科护理消毒液及其制备方法 | |
CN104825598A (zh) | 一种治疗风湿骨痛的外用膏药及其制备方法 | |
CN105031595A (zh) | 一种治疗钱币状湿疹的中药片剂及其制备方法 | |
CN104324114A (zh) | 治疗痢疾的中药制剂 | |
CN1682886A (zh) | 治疗风湿类风湿及慢性疼痛的外敷中药组合物 | |
CN103893517A (zh) | 一种治疗皮炎湿疹的中药混合物 | |
CN114028519A (zh) | 乌蛇消风丸 | |
CN114028486A (zh) | 蜂胶健胃丸 | |
CN114010741A (zh) | 前列消肿丸 | |
CN105770538A (zh) | 一种治疗血液透析患者血管通路局部硬结的中药 | |
CN105106533A (zh) | 一种治疗妊娠期胆结石的中药组合物 | |
CN114010713A (zh) | 肾衰康复丸 | |
CN105596852A (zh) | 治疗狐臭的软膏剂及其制备方法 | |
CN104524204A (zh) | 一种治疗创伤、恶疮的中药制剂及其制备方法 | |
CN112915171A (zh) | 一种治疗痛风的丸子 | |
CN103638506B (zh) | 一种治疗痹症的中药 | |
CN104436043A (zh) | 一种治疗疮疡阳证的止痛消炎药膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: Chen Fengyu Document name: Notification of qualified procedures |
|
DD01 | Delivery of document by public notice | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |